1. Maltoni M, Nanni O, Pirovano M, Scarpi E, Indelli M, Martini C, Monti M, Arnoldi E, Piva L, Ravaioli A, Cruciani G, Labianca R, Amadori D: Successful validation of the palliative prognostic score in terminally ill cancer patients. Italian multicenter study group on palliative care. J Pain Symptom Manage. 1999, 17: 240-247. 10.1016/S0885-3924(98)00146-8.
2. Strasser F, Bruera ED: Update on anorexia and cachexia. Hematol Oncol Clin North Am. 2002, 16: 589-617. 10.1016/S0889-8588(02)00011-4.
3. Lacquaniti A, Altavilla G, Picone A, Donato V, Chirico V, Mondello P, Aloisi C, Marabello G, Loddo S, Buemi A, Lorenzano G, Buemi M: Apelin beyond kidney failure and hyponatremia: a useful biomarker for cancer disease progression evaluation. Clin Exp Med. 2014, doi:10.1007/s10238-014-0272-y
4. Berenstein EG, Ortiz Z: Megestrol acetate for the treatment of anorexia-cachexia syndrome (Protocol for a Cochrane Review). Cochrane Libr. 2004, 4: 1-7.
5. Baiti NB, Walsh D: What is cancer anorexia-cachexia syndrome? A historical perspective. J R Coll Physicians Edinb. 2009, 39: 257-262.